These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9306128)

  • 1. Pre-analytical variation in the measurements of sensitive markers of coagulation and fibrinolysis: the influence of venipuncture and mixing of blood.
    Iversen LH
    Haemostasis; 1997; 27(3):119-24. PubMed ID: 9306128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of coagulation and fibrinolysis after fractures of the lower extremities.
    Sørensen JV; Rahr HB; Jensen HP; Borris LC; Lassen MR; Ejstrud P
    Thromb Res; 1992 Mar; 65(4-5):479-86. PubMed ID: 1615491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.
    Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C
    Scand J Gastroenterol; 1994 Jun; 29(6):516-21. PubMed ID: 8079109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of coagulation and fibrinolysis in blood drawn into citrate with and without D-Phe-Pro-Arg-Chloromethylketone (PPACK).
    Rahr HB; Sørensen JV; Danielsen D
    Thromb Res; 1994 Mar; 73(5):279-84. PubMed ID: 8016814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
    Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
    Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
    Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
    Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
    Takahashi H; Wada K; Niwano H; Shibata A
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex.
    Hafner G; Schinzel H; Ehrenthal W; Wagner C; Konheiser U; Zotz R; Lotz J; Blank R; Weilemann LS; Prellwitz W
    Ann Hematol; 1993 Sep; 67(3):121-5. PubMed ID: 8373897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
    Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
    Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
    Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
    Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation activity and clinical outcome in unstable coronary artery disease.
    Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
    Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
    Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
    Steinbrueckner BE; Steigerwald U; Keller F; Neukam K; Elert O; Babin-Ebell J
    Heart Vessels; 1995; 10(1):46-53. PubMed ID: 7730247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
    Sorano GG; Paoletti P; Casciu G; Mameli G; Marongiu F
    Haemostasis; 1997; 27(3):125-30. PubMed ID: 9306129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.